FDA has taken steps to embrace AI in 2025, announcing in December that it will be providing agency staff with agentic AI ...

AI’s true promise is turning clinical development from a bottleneck into a throughput engine for human health. Drug discovery ...

Less than six months after a series A fundraise, AI drug developer Chai Discovery has brewed up a $130 million series B to ...

Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage companies focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today outlined continued ...

The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This breakthrough has the potential to revolutionize drug discovery, transforming ...

Medra, a developer of AI-powered lab robots and scientists to advance drug discovery, raises $52M - SiliconANGLE ...

The FDA has qualified AI-Based Histologic Measurement of MASH, or AIM-MASH AI Assist — the first AI drug development tool — ...

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced it has won the ...

UB researcher Murali Ramanathan has used artificial intelligence (AI) since its nascent days while exploring possible treatments for multiple sclerosis (MS) and Alzheimer’s disease. Today, Ramanathan, ...

AI-leveraged drug development has become an $18 billion industry, but companies in the sector are experiencing some hardships. Beyond efforts to convenience investors their drugs are safe and ...